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Accurately measuring hormone exposure during prenatal life presents a methodological
challenge and there is currently no “gold standard” approach. Ideally, circulating fetal hor-
mone levels would be measured at repeated time points during pregnancy. However, it is
not currently possible to obtain fetal blood samples without significant risk to the fetus,
and therefore surrogate markers of fetal hormone levels must be utilized. Umbilical cord
blood can be readily obtained at birth and largely reflects fetal circulation in late gestation.
This review examines the accuracy and biological interpretation of the measurement of
androgens and estrogens in cord blood. The use of cord blood hormones to understand
and investigate human development is then discussed.
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Prenatal exposure to sex steroids has long been posited to influ-
ence human development (1, 2). There are a number of biological
differences between males and females, including height, weight,
internal reproductive anatomy, and external genitalia. Sex differ-
ences have also been observed in neuroanatomy and neurochem-
istry (3). In addition to biological differences, males and females
differ in a number of behavioral and cognitive aspects. Sex differ-
ences have been found for aggression (4, 5), childhood play (6),
visuospatial ability (7, 8), and verbal ability (9–11). However, the
examination of the relationship between these sex differences and
sex steroid exposure has been limited due to inherent difficul-
ties in providing accurate and reliable measurements of hormone
exposure during prenatal life.
Findings from animal models illustrate that exposure to sex
steroids during critical periods of gestational development can
have a significant long-term impact (12). However, due to the
many developmental differences between species (e.g., duration
of pregnancy, maturity at birth, and susceptibility to a variety
of environmental conditions), it is difficult to extrapolate animal
model findings to human development. Human brain and tissue
samples cannot realistically be collected for research purposes dur-
ing normal pregnancy, and it is not ethical to manipulate hormone
levels in human fetuses. Therefore, surrogate markers of fetal hor-
mone levels, such as the second-to-fourth digit (2D:4D) ratio or
the examination or clinical populations exposed to atypical hor-
mone levels (e.g., congenital adrenal hyperplasia), have been used
to investigate the relationship between sex steroids and human
development. However, there is doubt as to whether the 2D:4D
ratio is a reliable proxy measure of fetal testosterone levels (13, 14)
and it is difficult to extrapolate findings from clinical populations
to typical human development.
Alternatively, fetal hormones can be measured in amniotic fluid
from the second trimester of pregnancy onward. Amniotic sam-
ples provide an approximation of circulating fetal hormones by
gaging the hormone levels that have entered the amniotic fluid via
fetal urination or diffusion through fetal skin (15). While amniotic
hormones are thought to relate to hormone levels in fetal blood,
the strength of the relationship remains unclear. In addition, the
sampling procedure (amniocentesis) is generally only performed
in high-risk pregnancies and could not ethically be performed in
low risk pregnancies solely for research purposes.
Currently, there is no “gold standard” approach to the mea-
surement of prenatal hormone exposure (16). In response to
the methodological difficulties, researchers have sought alter-
native means through which prenatal hormone levels can be
approximated. Umbilical cord plasma collected at birth allows
for the collection of large representative samples and analysis
of archived samples. The current review will examine the bio-
logical interpretation of cord blood hormones, issues with assay,
and steroid comparisons in cord blood sex steroids and appli-
cations of this measurement approach to understanding human
development.
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BIOLOGICAL INTERPRETATION OF CORD BLOOD HORMONES
Pregnancy represents a unique phase of human life where circulat-
ing hormone concentrations are derived from maternal, placental,
and fetal origins. The developing fetal endocrine environment
is a function of gonadal, adrenal, and placental biosynthesis,
metabolism, and biodistribution, modulated by protein binding,
biological activity, and receptor affinity (17). The placenta is a
highly steroidogenic organ responsible for the production of large
amounts of free androgens and estrogens from fetal adrenal and
gonadal precursors (18, 19). The placenta is also a very active meta-
bolic organ with respect to phase II metabolism (conjugation).
While steroids are lipophilic and cross the placenta in both direc-
tions, most of them are metabolized by the placenta en route (20).
Fetal blood leaves the placenta (enriched with placental steroid
metabolites and some maternal steroids) via the umbilical vein
(UV) and returns from the fetus to the placenta via the umbilical
artery [UA; (21)].
Umbilical cord blood is typically collected after delivery near
term, and so cord plasma or serum hormone concentrations are
thought to reflect the levels in the fetal circulation at late gesta-
tion (22). Umbilical cord blood samples contain approximately
equal amounts of venous (UV) and arterial (UA) components,
although the relative proportions are usually not known precisely
and are not controlled for. Nevertheless, despite the differences in
UV and UA steroid concentrations, they are strongly correlated
(19). Ideally, fetal blood would be sampled earlier in pregnancy,
during critical periods of development, but this is not feasible for
ethical reasons. Hormone concentrations from maternal blood
samples collected during normal pregnancy have been suggested as
a possible approximation of circulating fetal concentrations (16).
However, several studies have shown that maternal sex steroid
concentrations do not reflect those in fetal circulation and the rela-
tionships are weak (23–25). Amniotic fluid sampled during mid
gestation provides a proxy measure of blood hormone concen-
tration in the fetus (15). However, the exact relationship between
hormone concentrations in amniotic-fluid and circulating fetal
concentrations remains unclear. Furthermore, due to the invasive
nature of amniocentesis it is restricted to high-risk pregnancies.
Currently, cord blood is the only practical means of assessing fetal
hormone levels during a typical pregnancy (26, 27).
It is important to note that the measurement of umbilical cord
sex steroids may be affected by a number of obstetric and maternal
factors. Fetal adrenal steroid production changes with gestational
age and labor, while levels of steroid-metabolizing enzymes in
the placenta are regulated by factors known to be associated
with labor and delivery such as glucocorticoids, pro-inflammatory
cytokines, and exposure to reactive oxygen species (18). Hence,
it is highly likely that factors such as prematurity, labor onset,
placental weight, intrauterine infection, and pre-eclampsia could
influence umbilical cord androgen levels, although the nature and
extent of their influence have not yet been fully determined. How-
ever, these relationships have recently been investigated in a large
unselected birth cohort; it was found that the presence and dura-
tion of labor and gestational age at delivery significantly impact
upon androgen and estrogen concentrations in cord blood (22,
28). In addition, birth weight and the presence of ante-partum
hemorrhage or pre-eclampsia significantly impact cord estrogen
levels (28). Some studies also suggest that smoking in pregnancy
may increase circulating postnatal testosterone and cortical con-
centrations and reduce estriol concentrations (29, 30), although
these relationships were not observed in the large cohort study of
Hickey et al. (28). Other maternal factors such as ethnicity, age, and
parity should also be controlled for when examining cord blood
hormones (22).
Another important consideration is that the major circulating
sex steroids (i.e., testosterone, estradiol, and estrone) are bound
to proteins such as sex hormone binding globulin (SHBG) and
albumin, which impacts upon their bioactivity (31). Albumin and
SHBG values vary according to gestational age at delivery and onset
of labor (22, 26). Therefore, accurate evaluation and interpreta-
tion of prenatal sex steroid concentrations requires adjustment
for pregnancy concentrations of albumin and SHBG in order to
determine the biologically active fraction (22, 26).
Normal values for sex steroid concentrations have been derived
from birth cohorts and consistently demonstrate that testosterone
concentrations are higher in males compared to females (25,
32, 33). Umbilical cord blood androgens are likely to reflect the
fetal androgen environment during late gestation. However, a
major limitation of the use of cord blood is that it is possible
that androgen influences on development may occur earlier in
gestation (34).
Unlike androgens, umbilical cord estrogen concentrations do
not consistently differ significantly between males and females.
Studies have reported inconsistent results including no sex dif-
ferences (24, 25, 28, 32, 33, 35), higher estrogen concentrations
in females (36), and higher estrogen concentrations in males (16,
37). The lack of consistent sex differences in estrogen concentra-
tions is biologically and clinically significant. Sex differences in
estrogen exposure and in the ratio of estrogen to testosterone
have been postulated to be responsible for a variety of sexu-
ally dimorphic neurodevelopmental and behavioral characteristics
including sexual orientation (38), reproductive function (12), and
cardiovascular disease (39).
It is clear from the literature reviewed that the collection of
cord blood plasma is useful as a measure of late gestation circu-
lating fetal hormones. However, it is important when measuring
cord hormone concentrations, to adjust for obstetric and mater-
nal confounding factors as well as to calculate the biological active
fractions of the sex steroids in order to derive valid conclusions.
ISSUES RELATED TO THE DETERMINATION OF STEROID
CONCENTRATIONS IN CORD BLOOD
Cord serum or plasma represents a particularly challenging
medium to analyze as it has an unusual steroid profile due to
the unique combination of placental and fetal steroid biosynthesis
and metabolism [conjugation and deconjugation; (40,41)]. There-
fore, assays require particularly careful validation to ensure that
the results are accurate. Due to the presence of a variety of steroid
isomers in cord blood with almost identical structures and frag-
mentation patterns, efficient chromatographic discrimination of
analytes during analysis can be particularly important – even when
using mass spectrometry as the detection methodology. Most pub-
lished studies have used radioimmunoassay (RIA) to measure
concentrations of estrogens and androgens in cord blood (16, 24,
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25, 37, 42–55). Organic solvent extraction has been employed in
most studies to remove interfering factors in order to improve
specificity, accuracy, and sensitivity. A few studies have used addi-
tional column purification techniques (24, 25, 53) to address
concerns regarding the accuracy of RIAs for the measurement of
low concentrations of steroids, in particular, testosterone (56, 57).
However, while the assays are sometimes tested and validated for
use in female or pediatric samples, their suitability for umbil-
ical cord blood analysis is usually assumed and invariably not
adequately tested.
Increasing awareness of the limitations of RIA for the measure-
ment of low concentrations of sex steroids (56, 58, 59) has led
to the adoption of mass spectrometry as the preferred method-
ology for the measurement of circulating testosterone levels in
women and children, and reported concentrations are consistently
lower than those derived by RIA (58, 60–63). A comparison of
estradiol and testosterone concentrations in cord blood reported
over the past few decades in numerous studies reveals the signif-
icant impact of assay methodology on the results obtained, and
thus the robustness of the data and any conclusions drawn from
it (Figure 1). Firstly, it is clear that some assays have reported
far higher ranges of these hormones than others, even for the
same type of assay; this is mostly apparent in the studies that
have employed RIA and raises real concerns around the validity
of some of these studies. Secondly, it is clear that much lower
values for testosterone are consistently reported in studies that
have employed mass spectrometry (either LC–MS/MS or GC–
MS) compared to immunoassay-derived values. On the other
hand, estradiol levels are overall not dramatically different between
RIA and mass spectrometry-based studies [with the exception
of the study by Lagiou et al. (46)]. Closer inspection of the
immunoassay studies, which reported the lowest testosterone val-
ues reveals that these assays employed column purification to help
remove interfering cross-reacting steroids (24, 25, 53). Neverthe-
less, these studies still reported values about 40% higher than those
reported by the largest study to date which employed an exten-
sively validated and internally controlled LC–MS/MS assay (22),
suggesting that chromatographic treatment was not completely
effective in removing all cross-reacting compounds prior to RIA
analysis.
Even within the mass-spectrometry studies, there are some-
times quite marked variations in reported values (22, 28, 35, 36,
41, 60). This can reflect variations in internal standardization and
extraction efficiency, with some studies measuring multiple hor-
mones and conjugates without controlling for extraction efficiency
of each specific analyte (35, 41). Inadequate chromatographic sep-
aration of similar steroid species prior to mass spectrometry is also
an important source of variation. However, there is also a great deal
FIGURE 1 |Variations in umbilical cord blood steroid concentrations
according to mode of assay. Steroid concentrations in cord blood are
displayed as mean± standard deviation or median and interquartile range,
depending on the data available. (A) 17β-estradiol concentrations in cord
blood (males and females combined) are displayed from 15 studies. The
first 11 utilized immunoassay (predominantly RIA); the remaining 4 used
LC–MS/MS, apart from the studies by Hill et al. (41), which used GC–MS.
(B)Testosterone concentrations in cord blood (males or mixed
male/female samples). Of the 17 studies included, the final 5 employed
mass spectrometry. The last study displayed on each chart has the largest
samples size (n=860) and extensive assay validation for cord blood. The
steroid values from the studies by Hill et al. (41) are the mean of the
published umbilical artery and vein values. The figure demonstrates the
influence of assay characteristics on sex steroid values, although the lack
of assay specificity is much more significant for measurement of
testosterone compared to estradiol.
www.frontiersin.org May 2014 | Volume 5 | Article 64 | 3
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hollier et al. Androgen and estrogen concentrations in cord blood
of variation in the nature of the specimens analyzed in the studies,
such that differences in mode of collection, ethnicity, gestational
age, labor onset and duration, rates of pregnancy complications,
twinning, and sample number/power are all likely to have a major
effect on the values obtained (22, 28).
APPLICATIONS OF CORD BLOOD TO UNDERSTANDING
HUMAN DEVELOPMENT
The literature reviewed provides general support for the use of
cord blood measurements to approximate prenatal sex steroid con-
centrations, although limitations regarding confounding by mode
of delivery and method of analysis need to be considered in the
interpretation. The remainder of this review will examine extant
applications of cord blood to understanding human behavioral
development.
To date, two research groups have used cord blood to exam-
ine the relationship between human development and exposure
to prenatal hormones (see Table 1). Jacklin and colleagues from
Stanford University examined a group of participants combined
from three longitudinal cohorts. Cohort one comprised infants
born at a university hospital during July and August 1973 (40
males, 35 females). The infants in cohorts two and three were
born at a nearby general hospital during January–March 1974
(32 males, 42 females) and August–November 1974 (53 males, 54
females), respectively. For offspring to be included in the study,
there needed to be no complications of pregnancy or delivery
and a 5-min Apgar score of 7 or above. Umbilical cord blood
(venous and arterial) was collected at birth and androstenedione,
testosterone, estrone, estradiol, and progesterone concentrations
were determined by RIA. Cord testosterone concentrations were
significantly higher in males than females. No sex differences
were observed for the androstenedione, estrone, estradiol, or
progesterone levels (33).
Timidity was measured through observation in 162 offspring
(84 males, 78 females) at 6, 9, 12, and 18 months (64). No
sex difference was found for the timidity measure. For boys,
Table 1 | Summary of the studies examining the relationship between cord hormone concentrations and human development.
Study Number of
participants
Age of
participants
Measures Findings
Hormones Assay technique Outcome measure
Jacklin
et al. (64)
84 males; 78
females
6, 9, 12, and
18 months
Androstenedione;
testosterone;
estrone; estradiol;
progesterone
RIA Timidity Males: significant negative relationship
with testosterone and progesterone,
positive relationship with estradiol
Females: no significant relationship
Jacklin
et al. (65)
127 children; Birth, 3, 6, 9,
12, 18, and
33 months
Androstenedione;
testosterone;
estrone; estradiol;
progesterone
RIA Muscular strength Males: significant negative relationship
with androstenedione, significant positive
relationship with progesterone
Females: significant negative relationship
with androstenedione and progesterone
Jacklin
et al. (66)
53 males; 43
females
6 years Androstenedione;
testosterone;
estrone; estradiol;
progesterone
RIA Reading;
Numeracy;
Listening; Spatial
ability
Males: no significant relationship
Females: significant inverse relationship
between testosterone and
androstenedione and spatial ability
Hollier et al.
(67)
224 males;
199 females
2 years Testosterone LC–MS Vocabulary Males: significant inverse relationship
Females: no significant relationship
Whitehouse
et al. (68)
372 males;
395 females
1–3 years Testosterone LC–MS Language delay Males: significant inverse relationship
Females: no significant relationship
Farrant
et al. (69)
235 males;
232 females
1 and 5 years Testosterone LC–MS Socio-emotional
engagement;
Vocabulary;
Males: no significant relationship after
control for covariates
Females: no significant relationship
Whitehouse
et al. (70)
184 males;
190 females
19–20 years Testosterone LC–MS Autism Quotient Males: no significant relationship
Females: no significant relationship
Robinson
et al. (71)
429 males;
430 females
2, 5, 8, and
10 years
Testosterone LC–MS Child Behavior
Checklist
Males: negative relationship between
testosterone and attention problems at
ages 5, 8, and 10 years
Females: negative association between
testosterone and withdrawal symptoms
at age 5
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testosterone and progesterone levels were significant negative
predictors of timidity, and estradiol levels were a significant posi-
tive predictor. No significant relationships were observed between
cord hormones concentrations and timidity for girls.
Jacklin et al. (65) investigated the relationship between umbil-
ical cord hormones and muscular strength measured at birth, 3,
6, 9, 12, 18, and 33 months in 127 children. On average, males
had greater strength scores than females. A significant negative
relationship was found between androstenedione and strength in
males and females. However, this relationship was found to be
reversed in one of the three cohorts, indicating the relationship is
not stable. A significant sex by progesterone interaction was found
in all three cohorts, where higher progesterone levels were related
to greater strength for males, but to lower strength for females.
The final study by Jacklin and colleagues examined cognitive
abilities in a subsample of 96 children (53 males, 43 females) when
they were 6 years old. No significant sex differences were found
for cognitive ability. A significant inverse relationship was found
between cord androgens (testosterone and androstenedione) and
spatial ability in girls. No significant associations were found for
boys (66).
The data yielded by Jacklin and colleagues indicate that the
direction of the association between cord blood hormones and
outcome measures may be different between males and females.
For boys, cord progesterone concentrations were positively asso-
ciated with strength in early childhood and negatively related to
timidity. For girls, cord progesterone was negatively associated
with early childhood strength and cord androgens (testosterone
and androstenedione) were inversely related to spatial ability.
It should be noted that Jacklin and colleagues measured cord
blood hormone concentrations by RIA following extraction and
purification. In addition, they used total hormone concentra-
tions, rather than the biologically active proportion. However,
the hormone levels reported were similar to a number of stud-
ies using mass spectrometry (see Figure 1) and their data appear
reliable.
The second research group utilized data from the Western
Australian Pregnancy Cohort (Raine) study. Between May 1989
and November 1991, 2900 pregnant women were recruited from
King Edward Memorial Hospital or nearby private practices. To
be included in the study, pregnant women had to have suffi-
cient English language skills, a gestational age between 16 and
18 weeks, an expectation to give birth at King Edward Memorial
Hospital Perth and an intention to remain within the state so as
to enable follow-up testing. Parents provided written informed
consent to participate at each follow-up. Approximately half of
the cohort (n= 1415) was randomly allocated to an intensive
investigation group, and within this group, mixed (venous and
arterial) umbilical cord blood was randomly collected from 861
live deliveries. Testosterone, androstenedione, dehydroepiandros-
terone (DHEA), estrone, estradiol, estriol, and estetrol concentra-
tions were estimated using LC–MS/MS. The bioavailable propor-
tion of testosterone was calculated, representing the fraction of
total testosterone either free (unsequestered by SHBG) or bound
to serum albumin. Males had significantly higher levels of cord
testosterone than females, while females had significantly higher
DHEA concentrations than males (22). There were no significant
sex differences for androstenedione, estrone, estradiol, estriol, or
estetrol (22, 28).
When offspring were 2 years of age, parents of 426 children
(224 male; 199 female) completed the Language Development
Survey [LDS; (72)]. Consistent with extensive published litera-
ture (73–75), it was found that on average boys had a smaller
expressive vocabulary than girls at 2 years of age. In addition, an
inverse relationship was found between cord blood testosterone
and expressive vocabulary,where higher levels of cord blood testos-
terone predicted lower vocabulary size in the boys. No relationship
was observed in girls (67).
When the offspring were 1, 2, and 3 years of age, parents of
767 children (395 males; 372 females) completed the 12, 24, and
36 month versions of the Infant Monitoring Questionnaire [IMQ;
(76)]. The IMQ is a parent report checklist, designed to screen for
delayed child development during the early years. Cut-off scores
are provided for each scale at each age to indicate a “clinically sig-
nificant” delay in the development of that particular skill. It was
found that males were between two and three times more likely
than females to experience language delay at 1, 2, and 3 years of
age. In addition, there was a significant association between cord
blood testosterone and the rate of language delay in both males
and females (70). In line with Hollier et al. (67), it was found that
higher levels of cord blood testosterone increased the risk of lan-
guage delay in males. Interestingly, for females, higher levels of
cord blood testosterone were found to be protective for language
delay. No significant relationship was observed between the other
IMQ scales and cord blood testosterone. The non-significant find-
ing on the Personal–Social scale of the IMQ is in contrast with
an inverse association reported by Knickmeyer et al. (77) between
amniotic-fluid testosterone levels and parent-reported social skills
in their sample of children at 4 years.
Farrant et al. (69) further explored the relationship between
cord blood testosterone, socio-emotional engagement, and lan-
guage development in a subset of 467 children from the Raine
sample (235 males, 232 females). Socio-emotional engagement
was assessed when the children were 1-year-old using a 14-item
Australian revision of the Toddler Temperament Scale (78). Vocab-
ulary was measured using the Peabody Picture Vocabulary Test –
Revised [PPVT-R; (79)], when the children were 5 years old. It
was found that cord blood testosterone was significantly nega-
tively correlated with socio-emotional engagement and vocabu-
lary in boys. In addition, for boys, socio-emotional engagement
was found to completely mediate the relationship between fetal
testosterone and vocabulary development. However, when various
covariates were included (e.g., maternal age and education, par-
ity, and parent–child book reading) neither fetal testosterone nor
socio-emotional engagement were significant predictors of vocab-
ulary development. No significant relationships were observed for
girls.
To further extend, the research examining the link between
socio-emotional engagement and cord blood testosterone, White-
house et al. (68) examined the relationship between cord testos-
terone and autistic-like traits in adulthood. When the offspring
were 19–20 years old 184 males and 190 females completed the
Autism-spectrum Quotient [AQ; (80)]. The AQ is a self-report
questionnaire, where individuals are provided with 50 statements
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and asked to indicate on a four-point scale how well that statement
applies to them. No significant relationship was found between
cord blood testosterone concentrations and AQ scores for either
males or females. This finding is in contrast with results from the
Cambridge Fetal Testosterone Project, which include reports of
significant associations between amniotic testosterone concentra-
tions and a range of autistic-like traits during early (77, 81, 82)
and middle (83) childhood.
The findings from Whitehouse et al. (70), Farrant et al. (69),
and Whitehouse et al. (68) indicate there may be no relationship
between socio-emotional development and cord blood testos-
terone at birth. These findings contrast with studies of mid-
pregnancy amniotic-fluid steroids, which indicate that socio-
emotional development may be related to testosterone exposure
during the earlier stages of gestation. The cord blood studies have
the advantage that they were conducted on a very large cohort
of typically developing infants, although steroid levels were mea-
sured at delivery, many weeks after the period expected to be
critical for steroid-modulated neurodevelopment. The amniotic-
fluid studies, on the other hand, were on relatively small num-
bers of selected pregnancies with elevated risk of genetic abnor-
malities, although samples were taken closer to the expected
steroid-sensitive developmental window.
Finally, Robinson et al. (71) investigated the relationship
between cord blood testosterone and internalizing and exter-
nalizing behavior in childhood for the Raine sample. Exter-
nalizing and internalizing behaviors were measured when the
children (429 males; 430 females) were 2, 5, 8, and 10 years
of ages using the Child Behavior Checklist [CBCL; (84, 85)].
The CBCL is a parent-rated questionnaire that includes a Total
Behavior Problem scale, an Externalizing Behavior scale (e.g.,
antisocial or under-controlled behavior), and an Internalizing
Behavior scale (e.g., inhibited or over-controlled behavior). In
addition, there are eight subscales: withdrawn behavior, somatic
complaints, anxiety/depression, delinquency, aggression, social
thought, and attention problems. No significant relationships
were found between cord blood testosterone and the CBCL
total, internalizing or externalizing scales at all ages. When
examining the individual subscales, a negative relationship was
found between cord testosterone and attention problems for
boys at ages 5, 8, and 10 years. For girls, there was a negative
association between cord testosterone and withdrawal symp-
toms at age five. The findings from Robinson et al. (71) did
not demonstrate a consistent relationship between fetal testos-
terone exposure and behavioral difficulties in childhood. How-
ever, significant relationships were observed for particular behav-
iors, which suggest there may be links between fetal testos-
terone exposure and behavioral development. Further research
is warranted to more thoroughly understand the relationship
between fetal testosterone exposure and behavioral difficulties in
childhood.
In summary, significant negative relationships have been con-
sistently observed between cord blood testosterone and early lan-
guage development. However, relationships between cord testos-
terone and other forms of development are still unclear. Some
studies indicate that high fetal testosterone exposure is related to
more male-typical behavior, while others have found that high
fetal testosterone is associated with less male-typical behavior. It
is important to note that the analysis of the Raine study samples
utilized the more accurate LC–MS/MS method, and calculated
the bioavailable proportion of testosterone, both of which add
strength to the quality of the data. The studies by Jacklin and col-
leagues, on the other hand, used a robust RIA but were limited
to the use of total hormone concentrations uncorrected for pro-
tein binding. To date, only a few studies have been conducted in
this area and relationships between cord testosterone and child-
hood development should be investigated more thoroughly in the
future. Furthermore, only Jacklin and colleagues have investigated
relationships between cord blood estrogens and early develop-
ment. Cord estrogen levels have been measured in the Western
Australian Pregnancy Cohort; however, the relationship between
cord estrogen concentrations and human development has not yet
been examined in the cohort.
CONCLUSION
The purpose of the current review was to examine the use of cord
blood to measure androgen and estrogen concentrations, and the
applicability of this method to understanding human develop-
ment. From the literature reviewed, it is apparent that cord blood
is useful in providing direct measurement of late gestational andro-
gen and estrogen concentrations. However, fetal steroid levels
around the time of birth are influenced by obstetric and peri-
natal factors. It is essential for the accuracy of analyses to take
these factors into account when examining associations between
cord steroid levels and biological endpoints.
Furthermore, it is important that research using cord blood to
measure sex steroids employs properly validated assays. This is to
ensure that cross-reacting substances are not measured in error,
which is particularly important for the measurement of testos-
terone concentrations. Most studies to date have used RIA, which
has recognized limitations for the measurement of low sex steroid
concentrations (56, 58, 59). Mass spectrometry is currently the
preferred method for the measurement of circulating hormones
in cord blood.
Relatively little research has been performed on cord blood to
examine the relationship between fetal hormone exposure and
human neurodevelopment. Most of the research in this area has
focused on testosterone concentrations. A significant negative
relationship between cord testosterone and early language devel-
opment has been consistently observed (67, 70). However, the
relationships between cord testosterone and other aspects of devel-
opment are still unclear. One of the main criticisms of the use of
cord blood to examine the hormonal influences of human devel-
opment is that hormone effects may occur earlier in gestation. The
strength of the relationship between fetal plasma levels at birth and
those in early to mid pregnancy is not known. One advantage of
cord blood is that it provides a measure of hormone exposure later
in gestational development. This is of particular importance given
that animal studies have found that the effects of hormones on
development are not restricted to the first two trimesters (12, 86).
Examining the congruence between hormones obtained during an
earlier period of gestation (e.g., via amniotic fluid) and hormones
obtained from cord blood is an urgent priority for this field of
research.
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To date, only Jacklin and colleagues have examined the rela-
tionship between cord blood estrogens and human development.
However, cord blood hormone concentrations were measured
using RIA (64–66). In addition, adjustments for protein bind-
ing were not taken into account. Therefore, it is difficult to draw
definitive conclusions from their findings. More research needs to
be conducted to examine the relationship between human devel-
opment and cord estrogen concentrations. Furthermore, based on
conflicting evidence of sex differences in cord estrogen concen-
trations (16, 24, 25, 28, 32, 33, 35–37), it has been suggested that
the ratio of androgens to estrogens may underlie sex-associated
developmental outcomes, rather than absolute concentrations.
Future research should investigate possible relationships between
the androgen to estrogen ratio and aspects of human development.
In conclusion, the collection of cord blood is currently the
most practical means of approximating circulating fetal hormones
in normal pregnancy. The use of cord blood to examine the
relationship between fetal hormones and human development is
promising, but requires validation and further investigation. It
is important that future research in this area uses properly val-
idated assays to determine hormone concentrations and takes
into account any possible confounding factors. The results of
studies that do not take these steps may lack accuracy and valid
interpretation.
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